During the corresponding time, Sanuwave Health Inc saw a revenue deteriorated by -4.18 % year on year, sequentially revenue grew by 1.25 %. While revenue at the Sanuwave Health Inc 's corporate clients
Sanuwave Health Inc's Comment on Sales, Marketing and Customers
Sanuwave sells UltraMIST systems and sterile, single-use applicators, with consumables accounting for approximately 58% of total revenues in 2025. As of December 31, 2025, there were 1,292 active systems owned by customers who recently ordered consumables. The company targets the wound care market in the United States, which is estimated to exceed $67 billion annually, serving patients with conditions related to aging, obesity, diabetes, cancers, and autoimmune disorders. Sanuwave focuses on direct sales and distribution within the U.S., with potential plans for international expansion. Their strategy emphasizes evidence-based medicine and shifting care from hospitals to patient locations to improve convenience and reduce infection risks. The company aims to provide cost-effective, user- and patient-friendly technology to physicians and patients, addressing barriers such as treatment duration, device complexity, and pain. Sanuwave targets patients seeking faster, less painful recovery; physicians requiring integrable care solutions; and payors interested in effective, early outpatient treatment with available CMS reimbursement.
Sanuwave Health Inc’s Comment on Sales, Marketing and Customers
Sanuwave sells UltraMIST systems and sterile, single-use applicators, with consumables accounting for approximately 58% of total revenues in 2025. As of December 31, 2025, there were 1,292 active systems owned by customers who recently ordered consumables. The company targets the wound care market in the United States, which is estimated to exceed $67 billion annually, serving patients with conditions related to aging, obesity, diabetes, cancers, and autoimmune disorders. Sanuwave focuses on direct sales and distribution within the U.S., with potential plans for international expansion. Their strategy emphasizes evidence-based medicine and shifting care from hospitals to patient locations to improve convenience and reduce infection risks. The company aims to provide cost-effective, user- and patient-friendly technology to physicians and patients, addressing barriers such as treatment duration, device complexity, and pain. Sanuwave targets patients seeking faster, less painful recovery; physicians requiring integrable care solutions; and payors interested in effective, early outpatient treatment with available CMS reimbursement.
Sources:
Sanuwave Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sanuwave Health Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sanuwave Health Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
143.37 %